Related references
Note: Only part of the references are listed.α-Mangostin: A Dietary Antioxidant Derived from the Pericarp of Garcinia mangostana L. Inhibits Pancreatic Tumor Growth in Xenograft Mouse Model
Bilal Bin Hafeez et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Shikonin suppresses tumor growth and synergizes with gemcitabine in a pancreatic cancer xenograft model: Involvement of NF-κB signaling pathway
Yongwei Wang et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Novel treatment option for MUC16-positive malignancies with the targeted TRAIL-based fusion protein Meso-TR3
Gunjal Garg et al.
BMC CANCER (2014)
Triptolide sensitizes pancreatic cancer cells to TRAIL-induced activation of the Death Receptor pathway
Zhiyu Chen et al.
CANCER LETTERS (2014)
Combination of AZD2281 (Olaparib) and GX15-070 (Obatoclax) results in synergistic antitumor activities in preclinical models of pancreatic cancer
Shaohua Chen et al.
CANCER LETTERS (2014)
Nuclear Death Receptor TRAIL-R2 Inhibits Maturation of Let-7 and Promotes Proliferation of Pancreatic and Other Tumor Cells
Verena Haselmann et al.
GASTROENTEROLOGY (2014)
Pulsatilla saponin A, an active molecule from Pulsatilla chinensis, induces cancer cell death and inhibits tumor growth in mouse xenograft models
Qiang Liu et al.
JOURNAL OF SURGICAL RESEARCH (2014)
Influence of the Implantation Site on the Sensitivity of Patient Pancreatic Tumor Xenografts to Apo2L/TRAIL Therapy
Rohit Sharma et al.
PANCREAS (2014)
Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells
J-S Zhang et al.
CELL DEATH & DISEASE (2014)
Effects of Garlic Oil on Pancreatic Cancer Cells
X. Y. Lan et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Synergism of Cytotoxicity Effects of Triptolide and Artesunate Combination Treatment in Pancreatic Cancer Cell Lines
Yao Liu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft
Junsheng Fu et al.
CANCER LETTERS (2013)
Targeting apoptosis pathways in pancreatic cancer
Alexander Arlt et al.
CANCER LETTERS (2013)
TRAIL-induced expression of uPA and IL-8 strongly enhanced by overexpression of TRAF2 and Bcl-xL in pancreatic ductal adenocarcinoma cells
Dong-Hui Zhou et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2013)
Antitumor effect of human TRAIL on adenoid cystic carcinoma using magnetic nanoparticle-mediated gene expression
Leiying Miao et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2013)
Phase 2, multicenter, open-label study of tigatuzumab (CS-1008), a humanized monoclonal antibody targeting death receptor 5, in combination with gemcitabine in chemotherapy-naive patients with unresectable or metastatic pancreatic cancer
Andres Forero-Torres et al.
CANCER MEDICINE (2013)
Zyflamend Sensitizes Tumor Cells to TRAIL-Induced Apoptosis Through Up-Regulation of Death Receptors and Down-Regulation of Survival Proteins: Role of ROS-Dependent CCAAT/Enhancer-Binding Protein-Homologous Protein Pathway
Ji Hye Kim et al.
ANTIOXIDANTS & REDOX SIGNALING (2012)
Doxorubicin-loaded human serum albumin nanoparticles surface-modified with TNF-related apoptosis-inducing ligand and transferrin for targeting multiple tumor types
Sungho Bae et al.
BIOMATERIALS (2012)
New Gene-Immunotherapy Combining TRAIL-Lymphocytes and EpCAMxCD3 Bispecific Antibody for Tumor Targeting
Ariane Groth et al.
CLINICAL CANCER RESEARCH (2012)
Wogonin and Related Natural Flavones Overcome Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Protein Resistance of Tumors by Down-regulation of c-FLIP Protein and Up-regulation of TRAIL Receptor 2 Expression
Jie Ding et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Dual Combination Therapy Targeting DR5 and EMMPRIN in Pancreatic Adenocarcinoma
Hyunki Kim et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Dihydroartemisinin Enhances Apo2L/TRAIL-Mediated Apoptosis in Pancreatic Cancer Cells via ROS-Mediated Up-Regulation of Death Receptor 5
Rui Kong et al.
PLOS ONE (2012)
Improved biological half-life and anti-tumor activity of TNF-related apoptosis-inducing ligand (TRAIL) using PEG-exposed nanoparticles
Sung Mook Lim et al.
BIOMATERIALS (2011)
Impact of death receptor signaling on the malignancy of pancreatic ductal adenocarcinoma
Christian Roeder et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2011)
Identification of c-FLIPL and c-FLIPS as critical regulators of death receptor-induced apoptosis in pancreatic cancer cells
Christian Haag et al.
GUT (2011)
A novel combination of TRAIL and doxorubicin enhances antitumor effect based on passive tumor-targeting of liposomes
Liangran Guo et al.
NANOTECHNOLOGY (2011)
TRAIL-Induced Apoptosis Is Preferentially Mediated via TRAIL Receptor 1 in Pancreatic Carcinoma Cells and Profoundly Enhanced by XIAP Inhibitors
Dominic Stadel et al.
CLINICAL CANCER RESEARCH (2010)
被撤回的出版物: γ-Tocotrienol Promotes TRAIL-Induced Apoptosis through Reactive Oxygen Species/Extracellular Signal-Regulated Kinase/p53-Mediated Upregulation of Death Receptors (Retracted article. See vol. 17, pg. 2072, 2018)
Ramaswamy Kannappan et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Development of a Genetically Engineered Biomimetic Vector for Targeted Gene Transfer to Breast Cancer Cells
Sriramchandra S. Mangipudi et al.
MOLECULAR PHARMACEUTICS (2009)
Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo
Meike Vogler et al.
CANCER RESEARCH (2008)
New Aspects of Regulatory Signaling Pathways and Novel Therapies in Pancreatic Cancer
Jannis Kountouras et al.
CURRENT MOLECULAR MEDICINE (2008)
Constitutively activated nuclear factor-κB, but not induced NF-κB, leads to TRAIL resistance by up-regulation of X-linked inhibitor of apoptosis protein in human cancer cells
Susanne J. Braeuer et al.
MOLECULAR CANCER RESEARCH (2006)
Preclinical characterization of AEG35156/GEM 640, a second-generation antisense oligonucleotide targeting X-linked inhibitor of apoptosis
Eric C. LaCasse et al.
CLINICAL CANCER RESEARCH (2006)
Predominant Bcl-XL knockdown disables antiapoptotic mechanisms:: Tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro
JR Bai et al.
CANCER RESEARCH (2005)
Selective targeting of the nuclear factor-κB pathway enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated pancreatic cancer cell death
RP Thomas et al.
SURGERY (2002)
CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-κB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells
A Trauzold et al.
ONCOGENE (2001)
Pancreatic adenocarcinoma cell lines show variable susceptibility to TRAIL-mediated cell death
SM Ibrahim et al.
PANCREAS (2001)
Effects and expression of TRAIL and its apoptosis-promoting receptors in human pancreatic cancer
F Ozawa et al.
CANCER LETTERS (2001)
Bcl-XL protects pancreatic adenocarcinoma cells against CD95-and TRAIL-receptor-mediated apoptosis
S Hinz et al.
ONCOGENE (2000)
Share Paper
